Related Experiment Videos
[Severe dysfunction of the left ventricle in patients with ischemic heart disease]
Insights
Diagnosing ischemic cardiomyopathy (ICMP) is practical using clinical and angiocardiographic data. Key markers include left ventricular dysfunction and reduced ejection fraction in patients with coronary artery disease.
Area of Science:
- Cardiology
- Medical Imaging
Context:
- Assessing ischemic cardiomyopathy (ICMP) diagnosis practicability.
- Utilizing clinical and angiocardiographic data in 32 coronary patients.
- Focusing on patients with left-ventricular diffuse hypo- and akinesia.
Purpose:
- To examine the practicability of diagnosing ischemic cardiomyopathy (ICMP).
- To identify specific angiocardiographic markers for ICMP diagnosis.
- To correlate clinical findings with diagnostic markers.
Summary:
- ICMP diagnosis is feasible with clinical and angiocardiographic data.
- Typical clinical signs include congestive heart failure, cardiomegaly, and ECG-indicated scar changes.
- Key diagnostic criteria involve increased ventriculographic volumes, diffuse left ventricular hypo-/akinesia, and ejection fraction <30% in patients with coronary artery disease.
Impact:
- Provides clear diagnostic criteria for ischemic cardiomyopathy.
- Aids clinicians in identifying ICMP more accurately.
- Highlights the importance of specific ventriculographic parameters and ejection fraction in diagnosis.
Abstract:
The practicability of the diagnosis of "ischemic cardiomyopathy (ICMP)" was examined on the basis of clinical and angiocardiographic data in 32 coronary patients with left-ventricular diffuse hypo- and akinesia, and its angiocardiographic markers were identified. The ICMP patients show a typical clinical picture, its major signs being congestive circulatory insufficiency, cardiomegaly and electrocardiographic evidence of large-focal scarry changes. The ICMP diagnosis is based on considerably increased ventriculographic volumetric parameters, and diffuse hypo- and akinesia of the left ventricle with the ejection fraction falling below 30% in patients with coronarographically-documented coronary arterial lesions.